REFR — Research Frontiers Income Statement
0.000.00%
Last trade - 00:00
- $66.37m
- $64.27m
- $0.91m
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.56 | 0.828 | 1.26 | 0.54 | 0.91 |
Cost of Revenue | |||||
Gross Profit | -2.11 | -1.95 | -1.26 | -2.02 | -1.45 |
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.71 | 3.2 | 3.1 | 3.16 | 2.94 |
Operating Profit | -3.15 | -2.38 | -1.84 | -2.63 | -2.03 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.81 | -2.34 | -1.85 | -2.67 | -1.91 |
Net Income After Taxes | -3.81 | -2.34 | -1.85 | -2.67 | -1.91 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.81 | -2.34 | -1.85 | -2.67 | -1.91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.81 | -2.34 | -1.85 | -2.67 | -1.91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.125 | -0.081 | -0.058 | -0.083 | -0.057 |